Inventor · disambiguated record
Li Zhang
Also filed as: ZHANG LI · ZHANG LI FENG · ZHANG LI-KANG
31 granted patents·24 pending applications·90 citations·filing 2002–2025
95Inventor score
Files withMEDSHINE DISCOVERY INC10AGIOS PHARMACEUTICALS INC7GUANGDONG RAYNOVENT BIOTECH CO LTD4UNIV SOUTH CAROLINA4BOEHRINGER INGELHEIM INT3
Top patents by PatentIndex Score
55 records- 0197US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0296US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 0394US12458647B2Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Granted Nov 4, 2025·1 cites·30 claims
- 0494US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 0590US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 0688US11597716B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 7, 2023·5 cites·20 claims
- 0786US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 0885US11014906B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2019·Granted May 25, 2021·3 cites·19 claims
- 0984US11433053B2LSD1 inhibitor and preparation method and application thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Sep 6, 2022·3 cites·30 claims
- 1083US10017495B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Jul 10, 2018·3 cites·17 claims
- 1182US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1279US10278973B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 7, 2019·2 cites·10 claims
- 1378US12172961B2Intermediate compounds and methodsBOEHRINGER INGELHEIM INT·Filed 2023·Granted Dec 24, 2024·0 cites·1 claims
- 1478US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
- 1574US11377444B2Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitorsMEDSHINE DISCOVERY INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 1671US12116356B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·20 claims
- 1771US10399981B2Crystal form A of 7-(cyclopropylmethyl)-1-(((cis )-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseasesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 1870US11603354B2Intermediate compounds and methodsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 14, 2023·0 cites·2 claims
- 1969US2020079755A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2067US2025144606A1Conjugated polymers infiltrated with inorganics for photocatalysisGEORGIA TECH RES INST·Filed 2024·Application pending·0 cites
- 2165US9550741B2Benzoisothiazole compounds and methods of treating schizophreniaSHANGHAI INST PHARMACEUTICAL IND·Filed 2014·Granted Jan 24, 2017·2 cites·12 claims
- 2265US2025312362A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2364US2025268907A1Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Application pending·0 cites
- 2461US2025326713A1INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOFMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2560US2011021620A1Use of tea polyphenols in preparing medicaments for prevention or treatment of tumorsZHANG LI·Filed 2009·Application pending·0 cites
- 2659US2025127906A1Small-molecule degraders of cdk8 and cdk19UNIV SOUTH CAROLINA·Filed 2022·Application pending·0 cites
- 2758US12281080B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2021·Granted Apr 22, 2025·0 cites·19 claims
- 2857US2020369611A1Intermediate compounds and methodsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2955USRE49128EHydroxyl purine compounds and applications thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2015·Granted Jul 12, 2022·0 cites·22 claims
- 3053US11649239B2Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1)MEDSHINE DISCOVERY INC·Filed 2019·Granted May 16, 2023·0 cites·12 claims
- 3152US12240811B2N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Mar 4, 2025·0 cites·4 claims
- 3250US2024408216A1Protein inhibitor or degrading agent, pharmaceutical composition containing same and pharmaceutical useJING MEDICINE TECH SHANGHAI LTD·Filed 2022·Application pending·0 cites
- 3350US2022267310A1Quinazoline and cinnoline derivatives as dna-pk inhibitorMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3449US10815231B2[1,2,4] triazolo [1,5-a] pyridine derivative and crystalline form thereofWEST CHINA HOSPITAL SICHUAN UNIV·Filed 2016·Granted Oct 27, 2020·0 cites·2 claims
- 3549US2023055321A1Pyrimidopyrrole spiro compounds and derivatives thereof as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3649US2013303604A1Method of Using Tea Polyphenols for Prevention and Treatment of Malignant Tumors in a Hematopoietic SystemZHANG LI·Filed 2013·Application pending·0 cites
- 3748US2023026616A1Pyrimidoimidazole compounds used as dna-pk inhibitorsMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 3848US2024109861A1Series of piperidine-substituted benzoic acid compounds, and use thereofMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 3946US8729280B2Five crystal forms, methods of preparation, pharmaceutical compositions and applications of XLF-III-43LV YANG·Filed 2009·Granted May 20, 2014·0 cites·7 claims
- 4046US2022260566A1Immunity mechanism and therapeutic drug for gastrointestinal diseasesGUANGZHOU WOMEN & CHILDRENS MEDICAL CT·Filed 2019·Application pending·0 cites
- 4146US2023338526A1Anti-cd20 antibody formulation and use of anti-cd20 antibody for treatment of cd20 positive diseasesBIO THERA SOLUTIONS LTD·Filed 2020·Application pending·0 cites
- 4246US2022306622A1Salt and crystal form of mtorc1/2 dual kinase activity inhibitor and preparation method thereforMEDSHINE DISCOVERY INC·Filed 2020·Application pending·0 cites
- 4345US11572369B2Bicyclic pyridine compositions and methods of using the same for cancer therapyUNIV SOUTH CAROLINA·Filed 2020·Granted Feb 7, 2023·0 cites·20 claims
- 4445US11155559B2Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activityCHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LTD·Filed 2018·Granted Oct 26, 2021·0 cites·11 claims
- 4544US10098885B2Hydroxyl purine compounds and applications thereofGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 16, 2018·0 cites·19 claims
- 4644US2022242851A1Crystal form and salt of quinazoline compound and preparation method thereofSHENZHEN JINRUI FOUND BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 4742US12030897B2Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 9, 2024·0 cites·14 claims
- 4842US2004129640A9Materials comprising polymers or oligomers of saccharides chemically bonded to a support useful for chromatography and electrophoresis applicationsUNIV SINGAPORE·Filed 2002·Application pending·0 cites
- 4942US2022401459A1New application of chemokine receptor ccr6 inhibitor in preventing recurrence of psoriasisRUIJIN HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE·Filed 2020·Application pending·0 cites
- 5041US10618898B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted Apr 14, 2020·0 cites·14 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Li Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →